Better Science, Better Health: New Healthcare Models

twitter-bird-bsbh-smallJoin the conversation on twitter #BSBH15

Speakers:

Click on the pictures for the biograhies

Sabine Atzor,

Director Regulatory Affairs,
Part time seconded from F.Hoffmann-La Roche to EFPIA

Richard Barker

Founding Director,
CASMI

Nancy Berg

CEO,
ISPOR

Jeff Brown

Associate Professor Population Medicine,
Harvard Medical School


Michael C Burgess, M.D.

US Congressman

Bill Cassidy, M.D.

United States Senator for Louisiana

Ruxandra Draghia-Akli

Director Health, DG Research and Innovation,
European Commission

David A. Dworaczyk

Director, Life and Health Sciences Strategic Development,
Oracle Health Sciences

Hans-Georg Eichler

Senior Medical Officer,
European Medicines Agency

Laura Esserman, MD MBA

Professor of Surgery and Radiology, Director UCSF Carol Franc Buck Breast Care Center

Pat Furlong

Founding President and CEO,
Parent Project Muscular Dystrophy

Sarah Garner

Associate Director Science Policy and Research,
National Institute for Health and Clinical Excellence (NICE)

Joseph P. Hammang

Partner,
Vital Transformation

Adam Heathfield

Senior Director Global Health and Value Innovation Center,
Pfizer

Gigi Hirsch

Executive Director,
MIT NEWDIGS

Ryan Hohman

Managing Director, Policy & Public Affairs,
Friends of Cancer Research

Lynn D. Hudson

Chief Science Officer for the Critical Path Institute (C-Path)

Alastair Kent

Director,
Genetic Alliance UK

Carol Linden

Director Office of Regulatory Science and Innovation,
FDA

Barbara Lopez Kunz

Global Chief Executive,
DIA

Pierre Meulien

Executive Director,
Innovative Medicines Initiative

Sandra A. Milligan,

Senior Vice President, Head of Regulatory Affairs and Safety
Merck Research Laboratories

Anders Olauson

President,
European Patients’ Forum

Kenneth Oye

Associate Professor of Political Science and Engineering Systems,
MIT

Dainius Pavalkis

Professor, Lithuanian University of Health Sciences

Mark Pearson

Deputy Director for Employment Labour and Social Affairs,
Organisation for Economic Co-operation and Development (OECD)

Arti K. Rai

Elvin R. Latty Professor of Law and co-Director, Duke Law Center for Innovation Policy,
Duke University

Bettina Ryll

Founder,
Melanoma Patient Network

Peter L. Saltonstall

CEO,
National Organization of Rare Disorders
(NORD)

Vicki Seyfort – Margolis

CEO,
My Own Med

Duane Schulthess

Managing Director,
Vital Transformation

Jonathan Sheldon

Global Vice President Healthcare,
Oracle Health Sciences

Mark Trusheim

Executive-in-Residence,
MIT

Jocelyn Ulrich

Senior Director, Science & Regulatory Advocacy,
PhRMA

Bart Vannieuwenhuyse

Senior Director Health Information Sciences,
Janssen Pharmaceuticals

Sheldon Whitehouse

United States Senator for Rhode Island

John Wubbe

Secretary General,
Epposi

Supported by:

Sponsored by: